Türk Karaciğer Araştırmaları Derneği


Professor of Medicine, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN
Internal Medicine
United States of America

Dr. Abdelmalek’s research focuses on the MASLD/MASH, associated risk factors for disease acquisition and progression and novel approaches to treatment. Her research has provided key insights into the association of fructose with MASLD acquisition and fibrosis progression. She has expertise in clinical-translational research, the design and conduct of clinical trials, including investigator-initiated, industry sponsored and NIH-funded clinical studies evaluating new therapies and biomarkers for MASLD/MASH. She collaborates extensively to transition new compounds to first-in-man clinical studies and translate clinic-to-bench and bench-to-clinic research to define pathogenic mechanisms underlying MASLD acquisition and progression. She is a member of the Liver Forum, and advisor / consultant to many industries, FDA, and biomarker development companies in the area of diagnostics and therapeutics for MASH. She is the Principal Investigator on several clincial trial, a member of the AASLD Global Outreach and Engagement Committee and past member of the AASLD and ACG Clinical Research Committees. Dr. Abdelmalek is a Fellow of American College of Physicians, American College of Gastroenterology, American Association for the Study of Liver Disease and an Associate Editor of HEPATOLOGY.